THE INFLUENCE OF PRETRANSPLANT LIPOPROTEIN ABNORMALITIES ON THE EARLY RESULTS OF RENAL-TRANSPLANTATION

被引:88
作者
DIMENY, E
TUFVESON, G
LITHELL, H
LARSSON, E
SIEGBAHN, A
FELLSTROM, B
机构
[1] UNIV HOSP UPPSALA,DEPT GERIATR,S-75185 UPPSALA,SWEDEN
[2] UNIV HOSP UPPSALA,DEPT PATHOL,S-75185 UPPSALA,SWEDEN
[3] UNIV HOSP UPPSALA,DEPT TRANSPLANTAT SURG,S-75185 UPPSALA,SWEDEN
[4] UNIV HOSP UPPSALA,DEPT CLIN CHEM,S-75185 UPPSALA,SWEDEN
关键词
ACUTE REJECTION; GRAFT DYSFUNCTION; LIPOPROTEINS; RENAL TRANSPLANTATION;
D O I
10.1111/j.1365-2362.1993.tb00968.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein patterns were investigated before and after renal transplantation in a prospective study including 151 patients. Kidney graft losses during the first 6 months were associated with higher total cholesterol (P = 0.03), LDL cholesterol (P=0.003) and LDL triglyceride levels (P=0.01) before transplantation. Patients with serum cholesterol greater-than-or-equal-to 6.9 mmol l-1 before transplantation had more acute rejections (1.7 vs. 0.9), a worse graft-function and more vascular intimal hyperplasia and 'glomerular mesangial changes in transplant biopsies at 6 months. Patients with serum creatinine levels exceeding 160 mumol l-1 at 6 months had more severe lipid disorders already before transplantation. Serum creatinine at 6 months was influenced by the number of acute rejection episodes (P=0.0001) and the age of the donor (P=0.009) while the number of acute rejections was found to be related to pretransplant total cholesterol levels (P=0.0086) and the age of the recipient (P=0.025). In conclusion, pretransplant lipoprotein disturbances have an impact on the early outcome of renal transplantation. Since there is a progresssion of hyperlipidaemia following transplantation, this may have an influence also on the cardiovascular morbidity and late graft dysfunction.
引用
收藏
页码:572 / 579
页数:8
相关论文
共 41 条
[1]   LIPID AND CARBOHYDRATE-METABOLISM IN UREMIA [J].
ATTMAN, PO ;
GUSTAFSON, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1979, 9 (04) :285-291
[2]  
BACKMAN U, 1989, TRANSPLANT P, V21, P762
[3]   LIPID ABNORMALITIES IN UREMIA, DIALYSIS, AND TRANSPLANTATION [J].
CHAN, MK ;
VARGHESE, Z ;
MOORHEAD, JF .
KIDNEY INTERNATIONAL, 1981, 19 (05) :625-637
[4]   RHABDOMYOLYSIS AND RENAL INJURY WITH LOVASTATIN USE - REPORT OF 2 CASES IN CARDIAC TRANSPLANT RECIPIENTS [J].
CORPIER, CL ;
JONES, PH ;
SUKI, WN ;
LEDERER, ED ;
QUINONES, MA ;
SCHMIDT, SW ;
YOUNG, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (02) :239-241
[5]  
DIMENY E, 1992, TRANSPLANT P, V24, P366
[6]  
ETTINGER WH, 1987, NEPHRON, V47, P12
[7]  
FEEHALLY J, 1986, LANCET, V2, P486
[8]  
FELLSTROM B, 1988, TRANSPLANT P, V20, P372
[9]  
FELLSTROM B, 1989, TRANSPLANT P, V21, P1435
[10]  
FELLSTROM B, 1990, CLIN EXP IMMUNOL, V80, P288